TLDR Chemotherapy for leukemia led to full hair regrowth in a child with alopecia totalis.
This document reports a unique case of complete remission of alopecia totalis (AT) in a pediatric patient following chemotherapy treatment for B-cell acute lymphoblastic leukemia (B-ALL). AT, characterized by non-scarring hair loss of the entire scalp due to autoimmune reactions, typically has an unpredictable clinical course with limited effective treatments. While remission of alopecia has been observed post-hematopoietic stem cell transplantation, this is the first documented instance of AT resolving solely after chemotherapy.
Cited in this study
3 / 3 results
191 citations
,
September 2018 in “British journal of dermatology/British journal of dermatology, Supplement” Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.
44 citations
,
April 2017 in “International Journal of Dermatology” No treatment is completely effective for alopecia totalis and alopecia universalis.
185 citations
,
December 2014 in “Journal of Investigative Dermatology” A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.
1 citations
,
November 2022 in “JAAD case reports” Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.
May 2022 in “Journal of Cosmetic Dermatology” Trimax-360 Serum, when used for 98 days, safely and effectively improves hair growth, thickness, and density without any side effects.
5 citations
,
January 2020 in “Journal of Dermatology” Temporal hair loss relates to overall scalp hair loss in women.
41 citations
,
December 2008 in “International Journal of Dermatology” South Korean women with hair loss have lower hair density and thickness compared to healthy women.
